These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8841028)

  • 21. [Folate antagonist].
    Morikawa N
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():146-8. PubMed ID: 25831740
    [No Abstract]   [Full Text] [Related]  

  • 22. A Phase I study of raltitrexed, an antifolate thymidylate synthase inhibitor, in adult patients with advanced solid tumors.
    Grem JL; Sorensen JM; Cullen E; Takimoto CH; Steinberg SM; Chen AP; Hamilton JM; Arbuck SG; McAtee N; Lawrence D; Goldspiel B; Johnston PG; Allegra CJ
    Clin Cancer Res; 1999 Sep; 5(9):2381-91. PubMed ID: 10499608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pemetrexed safety and dosing strategy.
    Niyikiza C; Hanauske AR; Rusthoven JJ; Calvert AH; Allen R; Paoletti P; Bunn PA
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):24-9. PubMed ID: 12571807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of folylpolygutamate synthetase (FPGS) in antifolate chemotherapy; a biochemical and clinical update.
    Synold TW; Willits EM; Barredo JC
    Leuk Lymphoma; 1996 Mar; 21(1-2):9-15. PubMed ID: 8907263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytoprotection: shelter from the storm.
    Klein P; Muggia FM
    Oncologist; 1999; 4(2):112-21. PubMed ID: 10337381
    [No Abstract]   [Full Text] [Related]  

  • 26. 5-Methyltetrahydrohomofolate.
    O'Dwyer PJ; Wagner BH; Hoth DF; Leyland-Jones B
    Invest New Drugs; 1987; 5(3):215-8. PubMed ID: 3312079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A semimechanistic-physiologic population pharmacokinetic/pharmacodynamic model for neutropenia following pemetrexed therapy.
    Latz JE; Karlsson MO; Rusthoven JJ; Ghosh A; Johnson RD
    Cancer Chemother Pharmacol; 2006 Apr; 57(4):412-26. PubMed ID: 16322990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Folate metabolism dysfunction].
    Righetti M
    G Ital Nefrol; 2008; 25(1):32-41. PubMed ID: 18264916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperpigmentation of the flexures and pancytopenia during treatment with folate antagonists.
    Jucgla A; Sais G; Berlanga J; Servitje O
    Acta Derm Venereol; 1997 Mar; 77(2):165-6. PubMed ID: 9111840
    [No Abstract]   [Full Text] [Related]  

  • 30. Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma.
    Galsky MD; Mironov S; Iasonos A; Scattergood J; Boyle MG; Bajorin DF
    Invest New Drugs; 2007 Jun; 25(3):265-70. PubMed ID: 17146733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia.
    Pakakasama S; Kanchanakamhaeng K; Kajanachumpol S; Udomsubpayakul U; Sirachainan N; Thithapandha A; Hongeng S
    Ann Hematol; 2007 Aug; 86(8):609-11. PubMed ID: 17323057
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma.
    Scagliotti GV; Shin DM; Kindler HL; Vasconcelles MJ; Keppler U; Manegold C; Burris H; Gatzemeier U; Blatter J; Symanowski JT; Rusthoven JJ
    J Clin Oncol; 2003 Apr; 21(8):1556-61. PubMed ID: 12697881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comments on "epileptogenic properties of folic acid and N5-methyltetrahydrofolate in cat".
    Smith DB; Obbens E
    Epilepsia; 1976 Mar; 17(1):35-6. PubMed ID: 1269490
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapeutic strategies targeting proteins that regulate folate and reduced folate transport.
    Trippett TM; Bertino JR
    J Chemother; 1999 Feb; 11(1):3-10. PubMed ID: 10078775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical and phase I clinical studies with the nonclassical antifolate thymidylate synthase inhibitor nolatrexed dihydrochloride given by prolonged administration in patients with solid tumors.
    Rafi I; Boddy AV; Calvete JA; Taylor GA; Newell DR; Bailey NP; Lind MJ; Green M; Hines J; Johnstone A; Clendeninn N; Calvert AH
    J Clin Oncol; 1998 Mar; 16(3):1131-41. PubMed ID: 9508200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase I and pharmacokinetic study of 1843U89, a noncompetitive inhibitor of thymidylate synthase, in patients with advanced solid malignancies.
    Schwartz G; Johnson TR; Goetz A; Burris H; Smetzer L; Lampkin T; Sailstad J; Hohneker JA; Von Hoff DD; Rowinsky EK
    Clin Cancer Res; 2001 Jul; 7(7):1901-11. PubMed ID: 11448903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of 5-fluorouracil-related stomatitis by oral cryotherapy: a randomized controlled study.
    Papadeas E; Naxakis S; Riga M; Kalofonos Ch
    Eur J Oncol Nurs; 2007 Feb; 11(1):60-5. PubMed ID: 16829196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug induced megaloblastic anemia].
    Wilmanns W
    Haematol Blood Transfus; 1978; 21():197-206. PubMed ID: 738634
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase I and pharmacokinetic study of pemetrexed administered every 3 weeks to advanced cancer patients with normal and impaired renal function.
    Mita AC; Sweeney CJ; Baker SD; Goetz A; Hammond LA; Patnaik A; Tolcher AW; Villalona-Calero M; Sandler A; Chaudhuri T; Molpus K; Latz JE; Simms L; Chaudhary AK; Johnson RD; Rowinsky EK; Takimoto CH
    J Clin Oncol; 2006 Feb; 24(4):552-62. PubMed ID: 16391300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: a potential role for growth factor as mucosal protectant.
    Meropol NJ; Rustum YM; Creaven PJ; Blumenson LE; Frank C
    Cancer Invest; 1999; 17(1):1-9. PubMed ID: 10999043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.